Ms. Ff. Mus. 471 - Misericordias Domini : C: A: T: B:, Violino primo, Violino secondo, Viola, Oboe pmo obl., Oboe sdo obl., Violoncello et Organo ; 1772

vom Seibert

Ms. Ff. Mus. 1261 - Dom: XXI post Trinit. : Mein Kind verwirff die Zucht pp ; C. A. T. B., violino primo, violino secondo, oboe primo, oboe secondo, viola, violoncello em organo

del Sige. Telemann. [Textverf.: Gottfried Simonis]

Ms. Ff. Mus. 1311 - Am 1. post Epiphan. : Sage mir an, du, den meine Seele liebet, pp. ; C. A. T. B., flauti et oboe, 2 violini, 1 viola, violoncello et organo

von Telemann. [Textverf.: Gottfried Simonis]

Ms. Ff. Mus. 1149 - Am Feste der Himmelfarth Christi : ich fahre auf zu meinem Vatter und zu eurem pp. ; C. A. T. B., 2 corni da caccia, 1 flauto, 2 violini, 2 oboe se piace, 1 viola, violoncello et organo

von Telemann. [Text von Gottfried Simonis]

Ms. Ff. Mus. 872 - Am Sonnt. nach Neu=Jahr : der Herr bewahret die Seelen seiner Heiligen ; C. A. T. B., 2 oboe ò flauti traversi, 2 violini, 1 viola, violoncello et organo

von Telemann. [Text: Gottfried Simonis]

Ms. Ff. Mus. 954 - Am 4. Advent : ein Weiser rühme sich nicht seiner Weisheit pp. ; C. A. T. B., 2 Violino, 2 Oboe se piace, 1 Viola, Violoncello et Organo

von Telemann

Ms. Ff. Mus. 1406 - Am 10 post Trinit. : Und als er nahe hinzu kam, sahe er die Stadt an ; pp. C. A. T. B., 2 violini, 2 oboe se piace, viola, violoncello et organo

von Telemann. [Text: Gottfried Simonis]

Kielflügel: J. B. Giusti, Lucca, ital. 1700, Kielflügel: Cristofori, 1703. 3 Manuale, Instrumentenabbildung, Sammlung der Pianofabrik J. C. Neupert, Internationale Ausstellung Musik im Leben der Völker, Frankfurt a. M., 1927

Signatur des Originals: S 36/F11366

Ms. Ff. Mus. 1323 - Am 2 post Epiphan. : Sehet an die Exempel der Alten, und pp. ; C. A. T. B. , 1 cornettino, 3 tromboni, 2 violini, 2 hautbois se piace, 1 viola, violoncello et organo.

von Telemann. [Textverf.: Gottfried Simonis]

Ms. Ff. Mus. 1413 - Uns ist ein Kind gebohren, ein Sohn ist uns pp. : am 1. Christ-Feyer-Tage ; C. C. A. T. B., 2 corni, 2 oboe, 2 violini, 1 viola, violoncello obligato et organo

von Telemann. [Text: Gottfried Simonis]

Ms. Ff. Mus. 973 - Am 4. post Epiphan. : Erwecke dich, Herr! Warum schläfest du? : C. A. T. B., 2 violini, 2 oboe, 1 viola, violoncello et organo

von Telemann

Post-biblical history of the Jews : from the close of the Old Testament, about the year 420 B.C.E. till the destruction of the second temple, in the year 70 C.E. ; in two volumes

by Morris J. Raphall

The epidemiology of Hepatitis B and Hepatitis C virus infection among college students who are not US/Canadian born in Houston

Introduction. A vast majority of studies conducted in both developed and developing nations have focused on the epidemiology of HBV (Hepatitis B virus) and HCV (Hepatitis C virus) in high-risk populations; low-risk populations have been neglected. Recently Hwang et al conducted a unique large cross-sectional study in American university students that focused on cosmetic procedures and drug use for acquiring these infections among a low-risk young adult population In Houston. ^ Methods. This study is a secondary data analysis of the cross-sectional study conducted by Hwang et al. Data for this anonymous study were collected from 7,960 college students, among whom were the 2,561 non US/Canadian born students included in this study. All students completed a self-administered questionnaire and provided a blood sample. The epidemiology of HBV/HCV and risk factors for acquiring HBV/HCV infection was studied by comparing those with HBV/HCV infection versus those without. Both univariate and multivariate logistic regression was used to analyze the data. ^ Results. Overall prevalence of HBV and HCV infections were 22% and 0.8% respectively. By multivariable analysis, the factors that were independently associated with increased prevalence of HBV infection were increasing age per year (OR=1.06, 95% C.I=1.04-1.08), Black or Asian race (OR=6.21, 95% C.I=3.14-12.27), history of household contact with hepatitis (OR=1.87, 95% C.I=1.15-3.05), and having sexual partner with hepatitis (OR=5.20, 95% C.I=1.5-18.00). For HCV these factors included increasing age per year (OR= 1.08, 95% C.I=1.03-1.14), history of blood transfusion prior to 1991 (OR=25.45, 95% C.I=7.58-85.40), and Injection drug use. (OR=78.15, 95% C.I=12.19-500.85). Cosmetic procedures like tattooing were not significant risk factors for either HBV or HCV infection. ^ Conclusions. In a low-risk adult foreign born population, cosmetic procedures are not significant risk factors for HBV or HCV infection. The prevention strategies of these infections in this population should focus on safe sexual practices/abstinence and HBV vaccination should be provided to adolescents and sexually active adults. ^

Alpha C protein of group B Streptococcus as a potential vaccine candidate

Group B Streptococcus (GBS) is a leading cause of life-threatening infection in neonates and young infants, pregnant women, and non-pregnant adults with underlying medical conditions. Immunization has theoretical potential to prevent significant morbidity and mortality from GBS disease. Alpha C protein (α C), found in 70% of non-type III capsule polysaccharide group B Streptococcus, elicits antibodies protective against α C-expressing strains in experimental animals and is an appealing carrier for a GBS conjugate vaccine. We determined whether natural exposure to α C elicits antibodies in women and if high maternal α C-specific serum antibody at delivery is associated with protection against neonatal disease. An ELISA was designed to measure α C-specific IgM and IgG in human sera. A case-control design (1:3 ratio) was used to match α C-expressing GBS colonized and non-colonized women by age and compare quantified serum α C-specific IgM and IgG. Sera also were analyzed from bacteremic neonates and their mothers and from women with invasive GBS disease. Antibody concentrations were compared using t-tests on log-transformed data. Geometric mean concentrations of α C-specific IgM and IgG were similar in sera from 58 α C strain colonized and 174 age-matched non-colonized women (IgG 245 and 313 ng/ml; IgM 257 and 229 ng/ml, respectively). Delivery sera from mothers of 42 neonates with GBS α C sepsis had similar concentrations of α C-specific IgM (245 ng/ml) and IgG (371 ng/ml), but acute sera from 13 women with invasive α C-expressing GBS infection had significantly higher concentrations (IgM 383 and IgG 476 ng/ml [p=0.036 and 0.038, respectively]). Convalescent sera from 5 of these women 16-49 days later had high α C-specific IgM and IgG concentrations (1355 and 4173 ng/ml, respectively). In vitro killing of α C-expressing GBS correlated with total α C-specific antibody concentration. Invasive disease but not colonization elicits α C-specific IgM and IgG in adults. Whether α C-specific IgG induced by vaccine would protect against disease in neonates merits further investigation. ^

Hepatitis B and C infections in U.S. incarcerated populations: Prevalence and related mortality

Published reports have consistently indicated high prevalence of serologic markers for hepatitis B (HBV) and hepatitis C (HCV) infection in U.S. incarcerated populations. Quantifying the current and projected burden of HBV and HCV infection and hepatitis-related sequelae in correctional healthcare systems with even modest precision remains elusive, however, because the prevalence and sequelae of HBV and HCV in U.S. incarcerated populations are not well-studied. This dissertation contributes to the assessment of the burden of HBV and HCV infections in U.S. incarcerated populations by addressing some of the deficiencies and gaps in previous research. ^ Objectives of the three dissertation studies were: (1) To investigate selected study-level factors as potential sources of heterogeneity in published HBV seroprevalence estimates in U.S. adult incarcerated populations (1975-2005), using meta-regression techniques; (2) To quantify the potential influence of suboptimal sensitivity of screening tests for antibodies to hepatitis C virus (anti-HCV) on previously reported anti-HCV prevalence estimates in U.S. incarcerated populations (1990-2005), by comparing these estimates to error-adjusted anti-HCV prevalence estimates in these populations; (3) To estimate death rates due to HBV, HCV, chronic liver disease (CLD/cirrhosis), and liver cancer from 1984 through 2003 in male prisoners in custody of the Texas Department of Criminal Justice (TDCJ) and to quantify the proportion of CLD/cirrhosis and liver cancer prisoner deaths attributable to HBV and/or HCV. ^ Results were as follows. Although meta-regression analyses were limited by the small body of literature, mean population age and serum collection year appeared to be sources of heterogeneity, respectively, in prevalence estimates of antibodies to HBV antigen (HBsAg+) and any positive HBV marker. Other population characteristics and study methods could not be ruled out as sources of heterogeneity. Anti-HCV prevalence is likely somewhat higher in male and female U.S. incarcerated populations than previously estimated in studies using anti-HCV screening tests alone without the benefit of repeat or additional testing. Death rates due to HBV, HCV, CLD/cirrhosis, and liver cancer from 1984 through 2003 in TDCJ male prisoners exceeded state and national rates. HCV rates appeared to be increasing and disproportionately affecting Hispanics. HCV was implicated in nearly one-third of liver cancer deaths. ^